KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancer

KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancer

Nan Zhang,1 Zhe Li,2 Wei Xiao,3 Fei Yang,4 Wei Gao,4 Zhi-Gang Sun3 1Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, People’s Republic of China; 2Department of Medical Examination, Jinan Central Hospital Affiliated to Shandong University, Shandong Un...

Full description

Bibliographic Details
Main Authors: Zhang N, Li Z, Xiao W, Yang F, Gao W, Sun ZG
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Cancer Management and Research
Subjects:
KLF6-SV1
Non-Small Cell Lung Cancer
real-time PCR
western blot
Immunohistochemistry
Online Access:https://www.dovepress.com/klf6-sv1-is-a-new-prognostic-biomarker-in-postoperative-patients-with--peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/klf6-sv1-is-a-new-prognostic-biomarker-in-postoperative-patients-with--peer-reviewed-article-CMAR

Similar Items